logoTry Persana

SFA Therapeutics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about SFA Therapeutics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

SFA Therapeutics company logo

A New Paradigm in Drug Development

SFA Therapeutics is a clinical stage start-up biotech company developing compounds discovered in the human microbiome to treat autoimmune and inflammatory diseases.

HeadquartersJenkintown, United States
Team size1-10
FoundedNA

What is SFA Therapeutics? - Company Overview & Details

SFA Therapeutics is SFA Therapeutics is a clinical stage start-up biotech company developing compounds discovered in the human microbiome to treat autoimmune and inflammatory diseases., the company is headquartered in Jenkintown, United States.

Who Founded SFA Therapeutics?

SFA Therapeutics is led by CEO Ira Spector.

Who are the Key Executives at SFA Therapeutics? - Leadership Team

SFA Therapeutics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of SFA Therapeutics

Ira SpectorCEO

Chief Technology Officer (CTO) of SFA Therapeutics

CTO

About Ira Spector - CEO of SFA Therapeutics

Ira Spector serves as the Chief Executive Officer of SFA Therapeutics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

SFA Therapeutics Company Details & Key Information

Where is SFA Therapeutics located?

SFA Therapeutics is headquartered in Jenkintown, United States.

How many employees does SFA Therapeutics have?

SFA Therapeutics has 1-10 employees.

SFA Therapeutics Official Website

How much funding has SFA Therapeutics raised?

SFA Therapeutics has raised $4.5 Million across 2 funding rounds. The most recent funding was completed on 2023-12-09.

Funding Overview

SFA Therapeutics has raised a total of $4.5 million in recent funding rounds to support its drug development efforts.

$4.5 Million
Total Funding Raised
2
Funding Rounds
2023-12-09
Latest Round

SFA Therapeutics Funding History

Series unknown
2023-12-09
$4.5 Million
Convertible note
2023-12-09
$4.5 Million

Who are the key investors in SFA Therapeutics?

SFA Therapeutics is backed by 1 key investors including North South Ventures. These investors focus on sectors.

SFA Therapeutics Investor Overview

1
Key Investors
0
Focus Areas
0
Notable Investments

Complete List of SFA Therapeutics Investors

North South Ventures

What sectors do SFA Therapeutics investors focus on?

The investors backing SFA Therapeutics primarily focus on sectors.

Featured Investor: North South Ventures

North South Ventures

Notable Investments:

What are SFA Therapeutics's future plans?

SFA Therapeutics SFA Therapeutics aims to advance its lead drug SFA-002 and navigate towards Phase 2 clinical trials.

SFA Therapeutics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does SFA Therapeutics face?

SFA Therapeutics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for SFA Therapeutics

1

Navigating clinical trials

2

Competing in the biotech market

What opportunities does SFA Therapeutics have?

SFA Therapeutics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for SFA Therapeutics

1

Expanding drug portfolio

2

Advancing innovative treatment approaches

SFA Therapeutics Strategic Position Summary

Key Focus Areas

SFA Therapeutics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about SFA Therapeutics?

SFA Therapeutics has 2 recent news updates covering key business developments and market activities.

SFA Therapeutics News Overview

2
Recent Articles
Active
Media Coverage
2025-03-07
Latest Update

What is SFA Therapeutics in the news for?

SFA Therapeutics is currently featured in news for SFA Therapeutics, Inc. attended event 2025 American Academy of Dermatology Annual Meeting on Mar 7th '25. and other significant business developments.

Recent News Articles About SFA Therapeutics

Article 1
2025-03-07

SFA Therapeutics, Inc. attended event 2025 American Academy of Dermatology Annual Meeting on Mar 7th '25.

SFA Therapeutics presented two posters on its psoriasis drug candidate SFA-002 at the American Academy of Dermatology Annual Meeting.

prnewswire.com
Read News
Article 2
2024-09-09

SFA Therapeutics, Inc. hired Ananda Gubbi as Director of Biostatistics on Aug 9th '24.

SFA Therapeutics appointed Dr. Ananda Gubbi as Director of Biostatistics to enhance its drug development capabilities.

mychesco.com
Read News

SFA Therapeutics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about SFA Therapeutics including information about founders, CEO, funding history, investors, headquarters location, and company details. 17 frequently asked questions covering key information about the company.

SFA Therapeutics Questions & Answers - Company Information

Q1

What is SFA Therapeutics?

SFA Therapeutics is a clinical stage start-up biotech company developing compounds discovered in the human microbiome to treat autoimmune and inflammatory diseases.

Q2

Who founded SFA Therapeutics?

SFA Therapeutics is led by CEO Ira Spector.

Q3

Who is the CEO of SFA Therapeutics?

The CEO of SFA Therapeutics is Ira Spector. You can find more information about them on their LinkedIn profile.

Q4

How much funding has SFA Therapeutics raised?

SFA Therapeutics has raised a total of $$4.5 Million across 2 funding rounds. The most recent funding was completed on 2023-12-09.

Q5

Who are the investors in SFA Therapeutics?

SFA Therapeutics's key investors include North South Ventures.

Q6

Where is SFA Therapeutics headquartered?

SFA Therapeutics is headquartered in Jenkintown, United States.

Q7

How many employees does SFA Therapeutics have?

SFA Therapeutics has 1-10 employees.

Q8

What is SFA Therapeutics's official website?

You can visit SFA Therapeutics's official website at http://www.sfatherapeutics.com.

Q9

What was SFA Therapeutics's latest funding round?

SFA Therapeutics's latest funding round was a Series unknown round of $$4.5 Million completed on 2023-12-09.

Q10

Who is founder?

Ira Spector

Q11

What does the company do?

SFA Therapeutics develops biopharmaceutical compounds derived from the human microbiome to treat autoimmune and inflammatory diseases.

Q12

How much funding?

$4.5 Million

Q13

Latest funding date?

2023-12-09

Q14

Who are the investors?

North South Ventures

Q15

What are the challenges?

Navigating clinical trials Competing in the biotech market

Q16

What are the opportunities?

Expanding drug portfolio Advancing innovative treatment approaches

Q17

Latest news?

SFA Therapeutics presented two posters on its psoriasis drug candidate SFA-002 at the American Academy of Dermatology Annual Meeting. SFA Therapeutics appointed Dr. Ananda Gubbi as Director of Biostatistics to enhance its drug development capabilities.

More Information About SFA Therapeutics

For additional details about SFA Therapeutics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.